Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).

Literature DB >> 6517561

In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).

R H Prabhala, B Rao, R Marshall, M B Bansal, H Thadepalli.

Abstract

About 80% of 70 clinical isolates of Bacteroides fragilis were inhibited by 4 micrograms of ciprofloxacin (Bay o 9867) per ml. The 90% MIC of ciprofloxacin was 8 micrograms/ml for other Bacteroides species, 2 micrograms/ml for Peptococcus species, 8 micrograms/ml for Peptostreptococcus species, and 16 micrograms/ml for Clostridium and Eubacterium species.

Entities: Chemical Species

Mesh：

Substances：

Year: 1984 PMID： 6517561 PMCID： PMC180016 DOI： 10.1128/AAC.26.5.785

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

5 in total

1. Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure.

Authors: A Arank; S A Syed; E B Kenney; R Freter
Journal: Appl Microbiol Date: 1969-04

2. Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors: B Crump; R Wise; J Dent
Journal: Antimicrob Agents Chemother Date: 1983-11 Impact factor: 5.191

3. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.

Authors: H L Muytjens; J van der Ros-van de Repe; G van Veldhuizen
Journal: Antimicrob Agents Chemother Date: 1983-08 Impact factor: 5.191

4. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors: R Wise; J M Andrews; L J Edwards
Journal: Antimicrob Agents Chemother Date: 1983-04 Impact factor: 5.191

5. In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.

Authors: I Roy; V Bach; H Thadepalli
Journal: Antimicrob Agents Chemother Date: 1977-02 Impact factor: 5.191

5 in total

14 in total

1. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors: J S Wolfson; D C Hooper
Journal: Antimicrob Agents Chemother Date: 1985-10 Impact factor: 5.191

2. The place of quinolones in antibacterial therapy in hospitals.

Authors: R P Mouton
Journal: Pharm Weekbl Sci Date: 1986-02-21

Review 3. Quinolone activity against anaerobes.

Authors: P C Appelbaum
Journal: Drugs Date: 1999 Impact factor: 9.546

Review 4. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors: J H Paton; D S Reeves
Journal: Drugs Date: 1988-08 Impact factor: 9.546

5. Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.

Authors: R A Venezia; D M Yocum; E M Robbiano; R M Echols
Journal: Antimicrob Agents Chemother Date: 1990-09 Impact factor: 5.191

6. Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

Authors: H Thadepalli; S V Gollapudi; S K Chuah
Journal: Antimicrob Agents Chemother Date: 1986-10 Impact factor: 5.191

7. Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.

Authors: M B Bansal; H Thadepalli
Journal: Antimicrob Agents Chemother Date: 1987-04 Impact factor: 5.191

8. Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.

Authors: J L Whiting; N Cheng; A W Chow
Journal: Antimicrob Agents Chemother Date: 1987-09 Impact factor: 5.191

Review 9. Quinolone activity against anaerobes: microbiological aspects.

Authors: P C Appelbaum
Journal: Drugs Date: 1995 Impact factor: 9.546

Review 10. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal: Drugs Date: 1988-04 Impact factor: 9.546